Approach
The Mapping Cancer Markers (MCM) project focuses on clinical application - discovering specific groups of markers that can be used to improve detection, diagnosis, prognosis and treatment of cancer. As a second goal, the comprehensive analysis of existing molecular profiles of cancer samples will lead to unraveling characteristics of such groups of markers - and in turn improving our understanding how to find them more efficiently.
Our strategy to reduce mortality includes three steps:
Increase number of cases diagnosed at earlier stage
We need to identify biomarkers for early cancer detection
Individualized treatment
We need to find biomarkers for treatment selection & response monitoring
Improved treatment
We need to improve our understanding of disease mechanism and drug mechanism_of_action
We need to identify useful drug combinations & design new medicines
To address these challenges, we propose to conduct an integrative analysis and comprehensive computational and biological validation of putative markers. To find all good markers, requires to use large patient cohorts (thousands of patient samples) and test billions of marker combinations, which would be intractable even on the
World Community Grid. Thus, we have developed software which uses heuristics (clever steps that reduce the enormous search space by focusing the search on the most relevant subsets of combinations) which can greatly reduce the computational effort required to look for significant marker patterns. Even these software methods require a very large amount of computer processing power. By using
World Community Grid, the Mapping Cancer Markers researchers are able to break down this overwhelming process into smaller, manageable tasks which can be performed by our volunteers' computing devices. World Community Grid therefore allows researchers to undertake this ambitious research. Thus, MCM focuses on three goals:
Identify sets of markers that may be able to predict if a person is at high risk of developing a particular cancer and increase the possibility of early detection.
Identify combinations of markers, which may predict a patient?s response to specific treatments. This would help make the treatment more personalized and could guide the development of customized therapeutic treatments for that patient.
Develop more efficient computational methods for discovering relevant patterns of markers.